Plant ID: NPO23768
Plant Latin Name: Camellia saluenensis
Taxonomy Genus: Camellia
Taxonomy Family: Theaceae
NCBI TaxonomyDB:
319929
Plant-of-the-World-Online:
n.a.
China
TSHR; | |
TRPA1; | |
MAPK1; | |
ALOX15; ALDH1A1; | |
MAPT; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Transient receptor potential channel | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | O75762 | CHEMBL6007 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.271E-05 | 2.767E-01 | CYP2A6, CYP3A4 |
BP | GO:0032501; multicellular organismal process | GO:0019233; sensory perception of pain | 2.627E-04 | 4.275E-01 | MAPK1, TRPA1 |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 2.727E-04 | 4.275E-01 | ALOX15, CYP2A6 |
BP | GO:0009987; cellular process | GO:0032273; positive regulation of protein polymerization | 1.067E-03 | 4.275E-01 | ALOX15, MAPT |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 4.200E-04 | 4.275E-01 | MAPK1, MAPT |
MF | GO:0003824; catalytic activity | GO:0016712; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 6.236E-05 | 4.275E-01 | CYP2A6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0050473; arachidonate 15-lipoxygenase activity | 1.397E-03 | 4.275E-01 | ALOX15 |
MF | GO:0003824; catalytic activity | GO:0070576; vitamin D 24-hydroxylase activity | 1.397E-03 | 4.275E-01 | CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004052; arachidonate 12-lipoxygenase activity | 1.397E-03 | 4.275E-01 | ALOX15 |
MF | GO:0003824; catalytic activity | GO:0051120; hepoxilin A3 synthase activity | 1.397E-03 | 4.275E-01 | ALOX15 |
CC | GO:0044464; cell part | GO:0032421; stereocilium bundle | 2.328E-03 | 5.113E-01 | TRPA1 |
CC | GO:0044464; cell part | GO:0030424; axon | 5.969E-03 | 7.973E-01 | MAPK1, MAPT |
CC | GO:0044464; cell part | GO:0030673; axolemma | 7.432E-03 | 8.562E-01 | MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.714E-06 | 2.768E-04 | CYP2A6, ALDH1A1, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 7.262E-05 | 3.704E-03 | ALOX15, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.844E-04 | 6.270E-03 | CYP2A6, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 4.157E-04 | 9.492E-03 | CYP2A6, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.653E-04 | 9.492E-03 | CYP2A6, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.436E-03 | 1.830E-02 | CYP2A6, ALOX15, ALDH1A1, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.091E-03 | 1.589E-02 | ALOX15, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 5.867E-04 | 9.975E-03 | CYP2A6, CYP3A4 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 2.429E-03 | 2.478E-02 | MAPK1, MAPT |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 2.248E-03 | 2.478E-02 | CYP2A6 |